TCIM
BLCM

TIAA CREF Investment Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

TIAA CREF Investment Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$528K Hold
15,656
– – ﹤0.01% 2579
2018
Q4 		$457K Sell
15,656
-35
-0.2% -$1.55K ﹤0.01% 2605
2018
Q3 		$967K Sell
15,691
-1,035
-6% -$70.1K ﹤0.01% 2435
2018
Q2 		$1.23M Buy
16,726
+1,459
+10% +$114K ﹤0.01% 2404
2018
Q1 		$1M Buy
15,267
+2,382
+18% +$180K ﹤0.01% 2446
2017
Q4 		$1.08M Buy
12,885
+400
+3% +$39.2K ﹤0.01% 2425
2017
Q3 		$1.44M Buy
12,485
+1,770
+17% +$186K ﹤0.01% 2335
2017
Q2 		$1.25M Buy
10,715
+4,957
+86% +$615K ﹤0.01% 2435
2017
Q1 		$711K Sell
5,758
-194
-3% -$25.4K ﹤0.01% 2671
2016
Q4 		$811K Sell
5,952
-666
-10% -$118K ﹤0.01% 2650
2016
Q3 		$1.32K Buy
6,618
+4
+0.1% +$689 ﹤0.01% 2395
2016
Q2 		$857K Buy
6,614
+3,852
+139% +$429K ﹤0.01% 2596
2016
Q1 		$258K Hold
2,762
– – ﹤0.01% 2941
2015
Q4 		$560K Hold
2,762
– – ﹤0.01% 2855
2015
Q3 		$401K Hold
2,762
– – ﹤0.01% 2951
2015
Q2 		$587K Buy
2,762
+1,099
+66% +$269K ﹤0.01% 2916
2015
Q1 		$385K Buy
+1,663
New +$402K ﹤0.01% 2978

Other funds holding BLCM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TIAA CREF Investment Management's BLCM Position: Q1 2019 in Review

TIAA CREF Investment Management held its Bellicum Pharmaceuticals, Inc. (BLCM) position steady in Q1 2019 at 15,656 shares worth $528K. The position accounts for ﹤0.01% of the portfolio, ranked #2579.

TIAA CREF Investment Management first reported a position in BLCM in Q1 2015 and has held it in 17 quarters since. The position peaked at $1.44M in Q3 2017. 94 funds tracked by Wall St. Rank hold BLCM as of Q1 2019.

  • TIAA CREF Investment Management held 15,656 shares of Bellicum Pharmaceuticals, Inc. worth $528K as of Q1 2019.
  • TIAA CREF Investment Management left its Bellicum Pharmaceuticals, Inc. share count unchanged in Q1 2019.
  • Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2579 holding.
  • TIAA CREF Investment Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and has held it in 17 quarters since.
  • TIAA CREF Investment Management's Bellicum Pharmaceuticals, Inc. position peaked at $1.44M in Q3 2017.
  • 94 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.